Insider · CIK 0001827672

Azamian Bobak R.

Reports to the SEC for 1 company · IRVINE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001827672

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-04	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−2,900 sh	$91.27	−$265K	827,991
2026-09-04	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−7,100 sh	$90.27	−$641K	830,891
2026-09-02	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−10K sh	$80.06	−$801K	837,991
2026-06-17	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−5,418 sh	$61.81	−$335K	847,991
2026-06-17	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−4,582 sh	$61.24	−$281K	853,409
2026-03-19	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−12K sh	$67.00	−$802K	33,421
2026-03-18	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−11.7K sh	$68.71	−$802K	45,385
2026-03-17	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−11K sh	$69.42	−$762K	57,052
2026-03-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President/CEO and Board Chair	MExercise/Conversion	−11.3K sh	—	—	0
2026-03-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President/CEO and Board Chair	MExercise/Conversion	−23.1K sh	—	—	46,243
2026-03-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President/CEO and Board Chair	MExercise/Conversion	−17K sh	—	—	16,975
2026-03-15	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Director, President/CEO and Board Chair	MExercise/Conversion	+66.3K sh	—	—	68,024
2026-03-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President/CEO and Board Chair	MExercise/Conversion	−14.9K sh	—	—	44,634
2026-03-05	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director, President/CEO and Board Chair	AAward	+60.8K sh	—	—	60,776
2026-03-05	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director, President/CEO and Board Chair	AAward	+96.7K sh	—	—	96,723
2025-12-24	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−5,443 sh	$82.41	−$449K	858,548
2025-12-24	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−557 sh	$83.54	−$46.5K	857,991
2025-12-04	TARSTarsus Pharmaceuticals, Inc.G Gift	Director, President/CEO and Board Chair	GGift	−51.9K sh	—	—	1,750
2025-09-24	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−6,000 sh	$55.37	−$332K	812,106
2025-08-11	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−6,000 sh	$50.00	−$300K	818,106
2025-03-24	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−6,000 sh	$50.00	−$300K	824,106
2025-03-20	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−8,534 sh	$50.11	−$428K	53,635
2025-03-19	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−8,551 sh	$47.40	−$405K	62,169
2025-03-18	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−7,131 sh	$46.29	−$330K	70,720
2025-03-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President/CEO and Board Chair	MExercise/Conversion	−23.1K sh	—	—	69,364
2025-03-15	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Director, President/CEO and Board Chair	MExercise/Conversion	+51.4K sh	—	—	77,851
2025-03-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President/CEO and Board Chair	MExercise/Conversion	−11.3K sh	—	—	11,300
2025-03-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President/CEO and Board Chair	MExercise/Conversion	−17K sh	—	—	33,950
2025-03-05	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director, President/CEO and Board Chair	AAward	+59.5K sh	—	—	59,512
2025-03-05	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director, President/CEO and Board Chair	AAward	+90.7K sh	—	—	90,736
2024-03-18	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−10.4K sh	$30.60	−$319K	26,456
2024-03-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President/CEO and Board Chair	MExercise/Conversion	−17K sh	—	—	50,925
2024-03-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President/CEO and Board Chair	MExercise/Conversion	−11.3K sh	—	—	22,599
2024-03-15	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Director, President/CEO and Board Chair	MExercise/Conversion	+28.3K sh	—	—	36,871
2024-03-07	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director, President/CEO and Board Chair	AAward	+137K sh	—	—	136,947
2024-03-07	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director, President/CEO and Board Chair	AAward	+92.5K sh	—	—	92,485
2023-12-27	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−8,000 sh	$20.22	−$162K	830,106
2023-12-20	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−9,443 sh	$19.96	−$188K	868,663
2023-12-20	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−30.6K sh	$20.36	−$622K	838,106
2023-11-15	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−4,904 sh	$18.54	−$90.9K	878,306
2023-11-15	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−2,896 sh	$18.01	−$52.2K	883,210
2023-11-15	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−200 sh	$19.28	−$3,856	878,106
2023-10-18	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−8,000 sh	$13.24	−$106K	886,106
2023-09-20	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−8,000 sh	$17.21	−$138K	894,106
2023-08-23	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−8,000 sh	$17.23	−$138K	902,106
2023-07-19	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−99.7K sh	$20.04	−$2M	910,106
2023-07-19	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−4,174 sh	$19.28	−$80.5K	1,009,832
2023-07-12	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−9,000 sh	$17.35	−$156K	1,014,006
2023-06-21	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−8,000 sh	$18.63	−$149K	1,023,006
2023-06-14	TARSTarsus Pharmaceuticals, Inc.S Sale	Director, President/CEO and Board Chair	SSale	−9,000 sh	$18.58	−$167K	1,031,006

Recent filings

Accepted (ET)
Sep 94
Azamian Bobak R.0001827672-26-000013
SEC(opens sec.gov)
Sep 34
Azamian Bobak R.0001827672-26-000011
SEC(opens sec.gov)
Jun 224
Azamian Bobak R.0001827672-26-000009
SEC(opens sec.gov)
Mar 194
Azamian Bobak R.0001827672-26-000007
SEC(opens sec.gov)
Mar 174
Azamian Bobak R.0001827672-26-000005
SEC(opens sec.gov)
Mar 94
Azamian Bobak R.0001827672-26-000003
SEC(opens sec.gov)
Dec 304
Azamian Bobak R.0001827672-25-000007
SEC(opens sec.gov)
Dec 84
Azamian Bobak R.0001827672-25-000005
SEC(opens sec.gov)
Sep 264
Azamian Bobak R.0001827672-25-000003
SEC(opens sec.gov)
Aug 134
Azamian Bobak R.0001819790-25-000110
SEC(opens sec.gov)

Companies

Tarsus Pharmaceuticals, Inc.Director, President/CEO and Board ChairTARS

Address

C/O TARSUS PHARMACEUTICALS, INC. 17700 LAGUNA CANYON ROAD, FLOOR 4

IRVINE, CA, 92618